Fidelity® Series Small Cap Opps (FSOPX)
18.05
+0.07 (+0.39%)
USD |
Apr 9
Returns Chart
Key Stats
Customize
| Expense Ratio | Total Assets Under Management | Dividend Yield | Turnover Ratio |
|---|---|---|---|
| -- | 6.036B | 0.75% | 61.00% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized All Time Total Returns (Daily) | Max Drawdown (All) |
| -963.16M | 69.27% | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| The investment seeks capital appreciation. The fund normally invests primarily in common stocks and invests at least 80% of assets in securities of companies with small market capitalizations (which, for purposes of this fund, are those companies with market capitalizations similar to companies in the Russell 2000® Index or the S&P SmallCap 600® Index). It invests in domestic and foreign issuers and allocates the fund's assets across different market sectors, using different Fidelity managers. The fund invests in either "growth" stocks or "value" stocks or both. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | FSOPX |
| Equity Style | Small Cap/Blend |
| Fixed Income Style | -- |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Category Name | Small Blend |
| Category Index | Russell 2000 TR USD |
| Prospectus Objective | Small Company |
| Fund Owner Firm Name | Fidelity Investments |
| Prospectus Benchmark Index | |
| Russell 2000 TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
| Manager Tenure | |
| Patrick Venanzi | 11.48 yrs |
| Shadman Riaz | 11.48 yrs |
| Morgen Peck | 10.07 yrs |
| Eirene Kontopoulos | 9.00 yrs |
Net Fund Flows Versus Category
1 Month
% Rank:
--
--
Category Low
--
Category High
1 Year
% Rank:
98
-963.16M
-3.812B
Category Low
6.839B
Category High
3 Months
% Rank:
--
--
Category Low
--
Category High
3 Years
% Rank:
--
--
Category Low
--
Category High
6 Months
% Rank:
--
--
Category Low
--
Category High
5 Years
% Rank:
--
--
Category Low
--
Category High
YTD
% Rank:
--
--
Category Low
--
Category High
10 Years
% Rank:
--
--
Category Low
--
Category High
As of March 31, 2021
Performance Versus Category
As of April 09, 2021. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
Edit comparables
As of April 09, 2021.
Asset Allocation
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
|
Fidelity Revere Str Tr
|
3.14% | -- | -- |
|
E-mini Russell 2000 Index Future Mar 21
|
2.64% | -- | -- |
| Novavax Inc | 1.07% | 179.74 | 1.97% |
| Darling Ingredients Inc | 0.86% | 74.07 | 2.53% |
| Caesars Entertainment Inc | 0.85% | 96.33 | 0.19% |
| Syneos Health Inc A | 0.84% | 80.00 | 1.71% |
| Builders FirstSource Inc | 0.81% | 48.60 | 2.65% |
| Phreesia Inc | 0.80% | 52.88 | 0.61% |
| TG Therapeutics Inc | 0.77% | 44.79 | -4.09% |
| II-VI Inc | 0.74% | 76.21 | -0.01% |
Basic Info
| Investment Strategy | |
| The investment seeks capital appreciation. The fund normally invests primarily in common stocks and invests at least 80% of assets in securities of companies with small market capitalizations (which, for purposes of this fund, are those companies with market capitalizations similar to companies in the Russell 2000® Index or the S&P SmallCap 600® Index). It invests in domestic and foreign issuers and allocates the fund's assets across different market sectors, using different Fidelity managers. The fund invests in either "growth" stocks or "value" stocks or both. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | FSOPX |
| Equity Style | Small Cap/Blend |
| Fixed Income Style | -- |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Category Name | Small Blend |
| Category Index | Russell 2000 TR USD |
| Prospectus Objective | Small Company |
| Fund Owner Firm Name | Fidelity Investments |
| Prospectus Benchmark Index | |
| Russell 2000 TR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
| Manager Tenure | |
| Patrick Venanzi | 11.48 yrs |
| Shadman Riaz | 11.48 yrs |
| Morgen Peck | 10.07 yrs |
| Eirene Kontopoulos | 9.00 yrs |
Fundamentals
| General | |
| Distribution Yield | Upgrade |
| Dividend Yield TTM (4-9-21) | 0.75% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Number of Holdings | Upgrade |
| Stock | |
| Weighted Average PE Ratio | 21.16 |
| Weighted Average Price to Sales Ratio | Upgrade |
| Weighted Average Price to Book Ratio | Upgrade |
| Weighted Median ROE | Upgrade |
| Weighted Median ROA | Upgrade |
| Forecasted Dividend Yield | Upgrade |
| Forecasted PE Ratio | Upgrade |
| Forecasted Price to Sales Ratio | Upgrade |
| Forecasted Price to Book Ratio | Upgrade |
As of January 31, 2021
Growth Estimates
Fund Details
| Key Dates | |
| Inception Date | 3/22/2007 |
| Last Annual Report Date | 7/31/2020 |
| Last Prospectus Date | 9/29/2020 |
| Attributes | |
| Enhanced Index Fund | No |
| Index Fund | No |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |